Wyeth litigation update
This article was originally published in The Tan Sheet
Executive Summary
Consumer Healthcare division reports second quarter and six-month gains of $40.3 mil. and $73.9 mil., respectively, from vitamin price-fixing litigation settlements, firm says in Aug. 8 110-Q filing. Separately, Wyeth notes it is a defendant in 412 phenylpropanolamine lawsuits - 401 individual product liability cases and 11 purported class actions. In June, a Seattle federal judge overseeing consolidated pretrial proceedings denied class certification in five actions, finding individual issues "clearly overwhelm any common questions, rendering class treatment inappropriate"...